← Back to patent-cliff list
CAS 133860-75-0
2-chloro-N4-isobutylquinoline-3,4-diamine
Codes: IMIQ-013
Application context (from source-drug indications)
Actinic keratosisImiquimod尖锐湿疣Imiquimod角化病ImiquimodBasal cell carcinomaImiquimod巨大尖锐湿疣Imiquimod人乳头瘤病毒感染Imiquimod
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Imiquimod | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-methylpropan-1-amine→2,4-dichloro-3-nitroquinoline→2-chloro-N4-isobutylquinoline-3,4-diamine→4-chloro-1-isobutyl-1H-imidazo[4,5-c]quinoline→4-chloro-1-isobutyl-1H-imidazo[4,5-c]quinoline→IMIQ-011
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.